Methods of treating myelodysplastic syndromes using lenalidomide | Patent Publication Number 20110172273

US 20110172273 A1

Patent NumberUS 08404717 B2

Application Number13070761

Filled DateMar 24, 2011

Priority DateOct 15, 2002

Publication DateJul 14, 2011

Original AssigneeBristol Myers Squibb

Current AssigneeCelgene

Inventor/ApplicantsJerome B. Zeldis

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.